Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name MIAT
   Synonyms MIAT, C22orf35, GOMAFU, LINC00066, NCRNA00066, RNCR2, lncRNA-MIAT, FLJ25967
   Region GRCh38_22:26646428-26676475    Sequence
   Ensembl ENSG00000225783
   RefSeq NR_003491
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name breast cancer
   ICD-0-3 C50  
   Methods qPCR, Western blot, in vitro knockdown, RNAi
   Sample breast tumor tissues, human breast cancer cells (MCF7, SKBR-3), human prostate cancer cells (PC-3, LNCaP), human brain cancer cells (A-172, U-87), neuroblastoma cell line (SH-SY5Y), human colon cancer cell lines (HT-29, SW48, SW480, SW1116), human stomach cancer cell (AGS), human cervix cell (HELA) and human liver hepatocellular carcinoma cell line (Hep G2)
   Expression Pattern up-regulated
   Function Description

MIAT expression was much higher in high-grade tumors compared to low-grade ones. Unlike P53 positive tumors, MIAT expression was upregulated in ER, PR, Her2 positive tumor tissues. An increase in the expression of mir-302, mir-150, and a decrease in the expression of mir-29c were detected following MIAT silencing. More importantly, knockdown MIAT significantly elevated the expression of p16Ink4A and Cox2, which commitment cellular senescence in breast cancer cells.

   Pubmed ID 29345338
   Year 2018
   Title MIAT lncRNA is overexpressed in breast cancer and its inhibition triggers senescence and G1 arrest in MCF7 cell line.
   External Links
   Links for  MIAT GenBank       HGNC       lncrnadb       Noncode
   Links for  breast cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.